Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin. [electronic resource]
Producer: 20060510Description: 126-31 p. digitalISSN:- 0735-7907
- Adenocarcinoma -- complications
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Appetite Stimulants -- administration & dosage
- Cachexia -- etiology
- Enzyme-Linked Immunosorbent Assay
- Female
- Hypercalcemia -- etiology
- Indomethacin -- administration & dosage
- Interleukin-1 -- blood
- Interleukin-6 -- blood
- Lung Neoplasms -- complications
- Matrix Metalloproteinase 2 -- blood
- Matrix Metalloproteinase 9 -- blood
- Medroxyprogesterone Acetate -- administration & dosage
- Mice
- Mice, Inbred BALB C
- Paraneoplastic Syndromes -- prevention & control
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.